AZD9412

Here's Why AstraZeneca Dipped 14.2% in October
Motley Fool
Thu, 11/10/16 - 10:22 am
AstraZeneca
AZD9412
durvalumab
Brilinta
AstraZeneca halts asthma study in blow to Synairgen
BioPharma Dive
Wed, 10/12/16 - 11:19 pm
AstraZeneca
asthma
Synairgen
clinical trials
AZD9412